De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence-Reference-Cited by-同舟云学术

De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence

Published:2022-01 Issue:1 Volume:22 Page:78-87
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Conte Benedetta^ORCID,Soldato Davide^ORCID,Razeti Maria Grazia,Fregatti Piero,de Azambuja Evandro,Schettini Francesco,Prat Aleix,Del Mastro Lucia,Lambertini Matteo^ORCID

Funder

Associazione Italiana per la Ricerca sul Cancro

Ministero della Salute

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference95 articles.

1. Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016;Deluche;Eur J Cancer,2020

2. Survival differences among women with de novo stage IV and relapsed breast cancer;Dawood;Ann Oncol,2010

3. Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients;McKenzie;Br J Cancer,2020

4. Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990–2010;Malmgren;Breast Cancer Res Treat,2018

5. Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort;Frank;Breast,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormone receptor-positive early breast cancer in young women: A comprehensive review;Cancer Treatment Reviews;2024-09

2. A Nomogram and Risk Classification System Predicting the Prognosis of Patients with De Novo Metastatic Breast Cancer Undergoing Immediate Breast Reconstruction: A Surveillance, Epidemiology, and End Results Population-Based Study;Current Oncology;2023-12-23

3. Clinicopathological Evaluation of Patients with Hormone Receptor–Positive HER2-Negative Metastatic Breast Cancer Progressing on Endocrine Treatment: A Real-World Retrospective Study from a Regional Cancer Center;South Asian Journal of Cancer;2023-12-08

4. HR+/HER2– de novo metastatic breast cancer: a true peculiar entity?;Drugs in Context;2023-03-06

5. Metastasis patterns and prognosis in young breast cancer patients: A SEER database analysis;Frontiers in Oncology;2022-10-13